Company

What you know and trust – now with a new shine

Our new design is here!  Clearer, more modern, more international.   With our new design and visual language we have achieved a strong visual alignment with the corporate identity of Revvity, Inc. At the same time, we harmonized the visual appearance of the Euroimmun and IDS brands creating a new modernized look which visually reflects our shared identity and growing collaboration.  But what really counts remains the same: our […]

Unveiling of the new logo from Euroimmun
Company

What you know and trust – soon with a new shine

Euroimmun is modernizing its brand appearance Our company has undergone significant developments in recent years. This will now also be reflected in our visual appearance. At the ADLM in Chicago (July 27–31, 2025), we will show you our new, modernized look for the first time, underlining our innovative power and our international orientation. But, of

Company

Two companies, one goal

SARS-CoV-2, the bird flu A(H7N9), MPox – several new and worrying diseases have appeared over the past years which are a great challenge to public health. In order to protect the population, the responsible health authorities have a range of measures at hand to fight and prevent epidemics. Besides the development of vaccines and medications,

Company

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

Press release Lübeck, 25 April 2024 Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This collaboration brings together EUROIMMUN’s extensive distribution network and support infrastructure with ALPCO-GeneProof’s

Scroll to Top